Evidence map›Paper›PMID 26294040›Full record

ArticleMolecular carcinogenesis2016

Persistent alterations of gene expression profiling of human peripheral blood mononuclear cells from smokers.

Daniel Y Weng, Jinguo Chen, Cenny Taslim, Ping-Ching Hsu, Catalin Marian, Sean P David, Christopher A Loffredo, Peter G Shields

Open access · greenAbstract read
In one paragraph

Article in Molecular carcinogenesis, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
0.5field-weighted citation impact, top 35% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 4 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Menthol Smokers: Metabolomic Profiling and Smoking Behavior.Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology · 2017
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 5 institutions in 2 countries.

Daniel Y WengComprehensive Cancer Center, The Ohio State University, Columbus, Ohio.
Jinguo ChenCenter for Human Immunology, National Institute of Health, Bethesda, Maryland.
Cenny TaslimComprehensive Cancer Center, The Ohio State University, Columbus, Ohio.
Ping-Ching HsuComprehensive Cancer Center, The Ohio State University, Columbus, Ohio.
Catalin MarianComprehensive Cancer Center, The Ohio State University, Columbus, Ohio.
Sean P DavidDepartment of Medicine, Stanford University School of Medicine, Stanford, California.
Christopher A LoffredoLombardi Comprehensive Cancer Center, Georgetown University Medical Center, Washington, District of Columbia.
Peter G ShieldsComprehensive Cancer Center, The Ohio State University, Columbus, Ohio. Peter.Shields@osumc.edu.
The Ohio State University · USGeorgetown University Medical Center · USNational Human Genome Research Institute · USStanford University · USVictor Babeș University of Medicine and Pharmacy Timișoara · RO

Funding

Translational Therapeutics Research Program (TT)P30CA016058 · NCI · OHIO STATE UNIVERSITY · PI Tasleem J Padamsee · 1985 to 2026
$132.3M
Tissue Culture Shared ResourceP30CA051008 · NCI · GEORGETOWN UNIVERSITY · PI STEPHEN W BYERS · 1990 to 2026
$71.5M
Project 4: Comprehension of Health Risks in More and Less Arousing Affe p240-275P50CA180908 · NCI · OHIO STATE UNIVERSITY · PI SHIELDS, PETER G., WEWERS, MARY ELLEN · 2013 to 2017
$18.9M
TRANSDISCIPLINARY TOBACCO USE RESEARCH CENTERSP50CA084718 · NCI · UNIVERSITY OF PENNSYLVANIA · PI LERMAN, CARYN · 1999 to 2008
$17.8M
MUTAGENESIS OF THE PRB POCKET DOMAINR01CA064402 · NCI · MASSACHUSETTS GENERAL HOSPITAL · PI DYSON, NICHOLAS J · 1994 to 2015
$4.1M
Psychobiological /Genetic Determinants-Smoking CessationK08DA014276 · NIDA · MEMORIAL HOSPITAL OF RHODE ISLAND · PI DAVID, SEAN P. · 2002 to 2006
$786k
NCI NIH HHS N01 PC064402NCI NIH HHS P30 CA016058NCI NIH HHS P30 CA051008NCI NIH HHS P50 CA084718NCI NIH HHS P50 CA180908NIDA NIH HHS K08 DA014276
6 · The paper itself

Abstract

The number of validated biomarkers of tobacco smoke exposure is limited, and none exist for tobacco-related cancer. Additional biomarkers for smoke, effects on cellular systems in vivo are needed to improve early detection of lung cancer, and to assist the Food and Drug Administration in regulating exposures to tobacco products. We assessed the effects of smoking on the gene expression using human cell cultures and blood from a cross-sectional study. We profiled global transcriptional changes in cultured smokers' peripheral blood mononuclear cells (PBMCs) treated with cigarette smoke condensate (CSC) in vitro (n = 7) and from well-characterized smokers' blood (n = 36). ANOVA with adjustment for covariates and Pearson correlation were used for statistical analysis in this study. CSC in vitro altered the expression of 1 178 genes (177 genes with > 1.5-fold-change) at P < 0.05. In vivo, PBMCs of heavy and light smokers differed for 614 genes (29 with > 1.5-fold-change) at P < 0.05 (309 remaining significant after adjustment for age, race, and gender). Forty-one genes were persistently altered both in vitro and in vivo, 22 having the same expression pattern reported for non-small cell lung cancer. Our data provides evidence that persistent alterations of gene expression in vitro and in vivo may relate to carcinogenic effects of cigarette smoke, and the identified genes may serve as potential biomarkers for cancer. The use of an in vitro model to corroborate results from human studies provides a novel way to understand human exposure and effect. © 2015 Wiley Periodicals, Inc.

Indexed as

Carcinoma, Non-Small-Cell LungCells, CulturedCross-Sectional StudiesDNAEarly Detection of CancerFemaleGene Expression ProfilingGene Expression RegulationGenetic Predisposition to DiseaseHumansLeukocytes, MononuclearLung NeoplasmsMaleMiddle AgedNicotianaOligonucleotide Array Sequence AnalysisDNASmokecigarette smokegene expressionperipheral blood mononuclear cells

Identifiers

PMID26294040
PMCPMC4860148
OpenAlexW1897950463

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.